Arvinas, Inc. announced that John Northcott has joined the company in a newly created position of Chief Commercial Officer (CCO). Mr. Northcott brings extensive U.S. and global experience in the development and commercialization of products, most notably including Avastin® and Imbruvica®. He recently served as CCO for Nektar Therapeutics and previously served as CCO for Pharmacyclics, an AbbVie Company, as well as Lexicon Pharmaceuticals.

Mr. Northcott has also held commercial leadership positions at companies including Genentech, a member of the Roche Group, Pfizer, Merck, and Pharmacia.